Model for end-stage liver disease-based allocation system for liver transplantation in Argentina: Does it work outside the United States?

HPB

Volumn 12, Issue 7, 2010, Pages 456-464

  McCormack, L ^a   Gadano, A ^b   Lendoire, J ^c   Imventarza, O ^d   Andriani, O ^e   Gil, O ^f   Toselli, L ^g   Bisigniano, L ^h   De Santibanes, E ^b  

^a HOSPITAL ALEMÁN   (Argentina)

^b HOSPITAL ITALIANO DE BUENOS AIRES   (Argentina)

^c Sanatorio Trinidad Mitre   (Argentina)

^d HOSPITAL GENERAL DE AGUDOS DR COSME ARGERICH   (Argentina)

^e UNIVERSIDAD AUSTRAL   (Argentina)

^f Sanatorio Allende   (Argentina)

^g Liver Transplant Unit   (Argentina)

^h INCUCAI ^*  (Argentina)

Author keywords

Ethical < transplant; Indications < transplant; Transplant

Indexed keywords

ADULT; AGED; ALCOHOL LIVER CIRRHOSIS; ARGENTINA; ARTICLE; AUTOIMMUNE HEPATITIS; CADAVER DONOR; CHOLESTATIC HEPATITIS; CHRONIC LIVER DISEASE; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED STUDY; DYING; ELECTIVE SURGERY; EMERGENCY SURGERY; END STAGE LIVER DISEASE; FEMALE; HEPATITIS C; HOSPITAL ADMISSION; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FAILURE; LIVER GRAFT; LIVER TRANSPLANTATION; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; OUTCOME ASSESSMENT; PROSPECTIVE STUDY; RESOURCE ALLOCATION; SCORING SYSTEM; UNITED STATES;

EID: 77956926542     PISSN: 1365182X     EISSN: 14772574     Source Type: Journal    
DOI: 10.1111/j.1477-2574.2010.00199.x     Document Type: Article

References (26)

1. Freeman RB, Wiesner RH, Edwards E, Harper A, Merion R, Wolfe R. (2004) Results of the first year of the new liver allocation plan. Liver Transpl 10:7-15.
2. Cholongitas E, Marelli L, Shusang V, Senzolo M, Rolles K, Patch D et al. (2006) A systematic review of the performance of the model for end-stage liver disease (MELD) in the setting of liver transplantation. Liver Transpl 12:1049-1061.
3. Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PC. (2000) A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 31:864-871.
4. Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL et al. (2001) A model to predict survival in patients with end-stage liver disease. Hepatology 33:464-470.
5. Freeman RB Jr. (2004) MELD and liver allocation: Continuous quality improvement. Hepatology 40:787-789.
6. de Santibanes E, Pekolj J, McCormack L, Nefa J, Mattera J, Sivori J et al. (2002) Liver transplantation for the sequelae of intra-operative bile duct injury. HPB (Oxford) 4:111-115.
7. de Santibanes E, Ardiles V, Gadano A, Palavecino M, Pekolj J, Ciardullo M. (2008) Liver transplantation: The last measure in the treatment of bile duct injuries. World J Surg 32:1714-1721.
8. Villamil F, Levy G, Grazi GL, Mies S, Samuel D, Sanjuan F et al. (2006) Long-term outcomes in liver transplant patients with hepatic C infection receiving tacrolimus or cyclosporine. Transplant Proc 38:2964-2967.
9. Yantorno SE, Varela EB, Raffa SR, Descalzi VI, Gomez Carretero ML, Pirola DA et al. (2005) How common is delayed cyclosporine absorption following liver transplantation? Liver Transpl 11:167-173.
10. Yantorno SE, Kremers WK, Ruf AE, Trentadue JJ, Podesta LG, Villamil FG. (2007) MELD is superior to King's college and Clichy's criteria to assess prognosis in fulminant hepatic failure. Liver Transpl 13:822-828.
11. Lendoire J, Raffin G, Cejas N, Duek F, Barros Schelotto P, Trigo P et al. (2007) Liver transplantation in adult patients with portal vein thrombosis: Risk factors, management and outcome. HPB (Oxford) 9:352-356.
12. Cueto G, Trigo P, Arata A, Rodriguez D, Brana E, Braslavsky G et al. (1999) Evaluation of prognostic factors for early infection in liver transplantation. Transplant Proc 31:3061-3062.
13. de Santibanes E, McCormack L, Mattera J, Pekolj J, Sivori J, Beskow A et al. (2000) Partial left lateral segment transplant from a living donor. Liver Transpl 6:108-112.
14. McCormack L, Quinonez EG, Capitanich P, Chao S, Serafini V, Goldaracena N et al. (2009) Acute liver failure due to concomitant arterial, portal and biliary injury during laparoscopic cholecystectomy: Is transplantation a valid life-saving strategy? A case report. Patient Saf Surg 3:22.
15. Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK et al. (2001) Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 35:421-430.
16. INCUCAI: Instituto Nacional Central Unico Coordinador de Ablacion e Implante. Argentina. http://www.incucai.gov.ar [accessed 26 July 2009].
17. Merion RM, Schaubel DE, Dykstra DM, Freeman RB, Port FK, Wolfe RA. (2005) The survival benefit of liver transplantation. Am J Transplant 5:307-313.
18. Austin MT, Poulose BK, Ray WA, Arbogast PG, Feurer ID, Pinson CW. (2007) Model for end-stage liver disease: Did the new liver allocation policy affect waiting list mortality? Arch Surg 142:1079-1085.
19. Halldorson JB, Bakthavatsalam R, Fix O, Reyes JD, Perkins JD. (2009) D-MELD, a simple predictor of post liver transplant mortality for optimization of donor/recipient matching. Am J Transplant 9:318-326.
20. Bonney GK, Aldersley MA, Asthana S, Toogood GJ, Pollard SG, Lodge JP et al. (2009) Donor risk index and MELD interactions in predicting longterm graft survival: A single-centre experience. Transplantation 87:1858-1863.
21. Philosophe B, Barlett ST. (2007) Model for end-stage liver disease: Did the new liver allocation policy affect waiting list mortality? Invited critique. Arch Surg 142:1086.
22. Wiesner RH. (2005) Patient selection in an era of donor liver shortage: Current US policy. Nat Clin Pract Gastroenterol Hepatol 2:24-30.
23. Ruf AE, Kremers WK, Chavez LL, Descalzi VI, Podesta LG, Villamil FG. (2005) Addition of serum sodium into the MELD score predicts waiting list mortality better than MELD alone. Liver Transpl 11:336-343.
24. Samuel D. (2009) MELD-Na as a prognostic score for cirrhotic patients: Hyponatremia and ascites are back in the game. J Hepatol 50:836-838.
25. Trotter JF, Olson J, Lefkowitz J, Smith AD, Arjal R, Kenison J. (2007) Changes in international normalized ratio (INR) and model for endstage liver disease (MELD) based on selection of clinical laboratory. Am J Transplant 7:1624-1628.
26. Perkins JD, Halldorson JB, Bakthavatsalam R, Fix OK, Carithers RL Jr, Reyes JD. (2009) Should liver transplantation in patients with model for end-stage liver disease scores